The early changing pattern of the B-type natriuretic peptide concentration and its significance as a prognostic marker after acute myocardial infarction

Korean Circulation Journal

Volumn 36, Issue 7, 2006, Pages 526-534

  Choe, Hyunmin ^a   Yoo, Byung Su ^a   Ryu, Ho Yeol ^a   Koh, Sang Baek ^a   Chang, Sei Jin ^a   Hwang, Sung Oh ^a   Kim, Jang Young ^a   Lee, Seung Whan ^a   Yoon, Junghan ^a   Choe, Kyung Hoon ^a  

^a Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

B type natriuretic peptide; Myocardial infarction; Prognosis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEART DEATH; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PROGNOSIS;

EID: 33747771370     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2006.36.7.526     Document Type: Article

References (24)

1. de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriureuc peptide in patients with acute coronary syndromes. N Engl J Med 2001;345:1014-21.
2. Yoo BS, Kim WJ, Jung HS, et al. The clinical experience of B-type natriuretic peptide blood concentrations for diagnosis in congestive heart failure. Korean Circ J 2004;34:684-92.
3. Baek KK, Jeon ES, Rhee I, et al. N-terminal pro-B-type natriuretic peptide as a prognostic marker in acute coronary syndrome. Korean Circ J 2004;34:1070-81.
4. Richard AM, Nicholls MG, Espiner EA, et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 2003;107:2786-92.
5. Omland T, Aakvaag A, Bonarjee VV, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996;93:1963-9.
6. Wang HS, Yoo BS, Chung IH, et al. Is B-type natriuretic peptide measurement useful test for diagnosing systolic heart failure in patients with moderate to severe renal insufficiency? Korean Circ J 2005;35:897-903.
7. Kim YJ, Chae SC, Lee JT. Changes in plasma levels of brain natriuretic peptide during exercise in patients with ischemic heart disease. Korean Circ J 2001;31:625-36.
8. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-7.
9. Omland T, Aakvaag A, Vik-Mo H. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment. Heart 1996;76:232-7.
10. Hirayama A, Yamamoto H, Sakata Y, et al. Usefulness of plasma brain natriuretic peptide after myocardial infarction in predicting left ventricular dilatation after six months later. Am J Cardiol 2001;88:890-3.
11. McKey R, Pfeffer JM, Pastemark R, et al. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation 1986;74:693-702.
12. Morita E, Yasue H, Yoshimura M, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1993;88:82-91.
13. Suzuki S, Yoshimura M, Nakayama M, et al. Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction. Circulation 2004;110:1387-91.
14. Heeschen C, Hamm CW, Mitrovic V, et al. N-terminal pro brain natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndrome. Circulation 2004;110:3206-12.
15. Choi EY, Kwon HM, Yoon YW, Kim D, Kim HS. Assessment of extent of myocardial ischemia in patients with non-ST elevation acute coronary syndrome using serum B-type natriuretic peptide level. Yonsei Med J 2004;45:255-62.
16. Talwar S, Squire IB, Downie PF, et al. Profile of plasma N-terminal proBNP following acute myocardial infarction. Eur Heart J 2000;21:1514-21.
17. Schiller NB, Shah PM, Crawfold M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-67.
18. Morita E, Yasue H, Yoshimura M, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1993;88:82-91.
19. Sumida H, Yasue H, Yoshimura M, et al. Comparison of secretion pattern between A-type and B-type natriuretic peptides in patients with old myocardial infarction. J Am Coll Cardiol 1995;25:1105-10.
20. Berger R, Huelsman M, Strecker K, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002;105:2392-7.
21. Arakawa N, Nakamura M, Aoki H, Hiramori K. Plasma brain natriuretic peptide concentration predict survival after acute myocardial infarction. J Am Coll Cardiol 1996;27:1656-61.
22. Darbar D, Davidson NC, Gillespie N, et al. Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction. Am J Cardiol 1996;78:284-7.
23. James SK, Lindahl B, Siegbahn A, et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease. Circulation 2003;108:275-81.
24. Omland T, Persson A, Ng L, et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 2002;106:2913-8.